BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15934430)

  • 1. [Recommendations for the clinical use of cardiac natriuretic peptides].
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
    Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain natriuretic peptide and acute coronary syndrome.
    Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N
    Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical applications of brain natriuretic peptide testing].
    Scardovi AB; ; ; ; ;
    Ital Heart J Suppl; 2004 May; 5(5):343-56. PubMed ID: 15182061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natriuretic peptides in patients with ischemic heart disease].
    Yoshimura M; Ogawa H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():88-92. PubMed ID: 15506344
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atrial natriuretic peptides: a new diagnostic tool for the internist].
    Boari B; Manfredini R; Fellin R
    Recenti Prog Med; 2005 Jun; 96(6):300-10. PubMed ID: 16078761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial natriuretic peptides: diagnostic and therapeutic potential].
    Brockhoff C; Warnholtz A; Münzel T
    Ther Umsch; 2000 May; 57(5):305-12. PubMed ID: 10859990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes.
    de Lemos JA; Morrow DA
    Am Heart J; 2007 Apr; 153(4):450-3. PubMed ID: 17383278
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natriuretic hormones in the diagnostics of heart failure].
    Laine M; Nieminen MS; Tikkanen I
    Duodecim; 1998; 114(19):1973-80. PubMed ID: 11717753
    [No Abstract]   [Full Text] [Related]  

  • 10. B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction.
    Zhang Y; Wang L
    Med Hypotheses; 2006; 67(5):1076-8. PubMed ID: 16697117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma brain natriuretic peptide-guided therapy not yet justified.
    Hoppe UC
    J Am Coll Cardiol; 2007 Nov; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
    [No Abstract]   [Full Text] [Related]  

  • 12. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial.
    Lainchbury JG; Troughton RW; Frampton CM; Yandle TG; Hamid A; Nicholls MG; Richards AM
    Eur J Heart Fail; 2006 Aug; 8(5):532-8. PubMed ID: 16829189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
    Shelton RJ; Goode K; Cleland JG
    Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
    [No Abstract]   [Full Text] [Related]  

  • 14. The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.
    Liu P; Arnold JM; Belenkie I; Demers C; Dorian P; Gianetti N; Haddad H; Howlett J; Ignazewski A; Jong P; McKelvie R; Moe G; Parker JD; Rao V; Rouleau JL; Teo K; Tsuyuki R; White M; Huckel V; Issac D; Johnstone D; LeBlanc MH; Lee H; Newton G; Niznick J; Ross H; Roth S; Roy D; Smith S; Sussex B; Yusuf S;
    Can J Cardiol; 2003 Mar; 19(4):347-56. PubMed ID: 12704478
    [No Abstract]   [Full Text] [Related]  

  • 15. B-type natriuretic peptide in heart failure.
    Colli A; Fraquelli M; Conte D
    N Engl J Med; 2002 Dec; 347(24):1976-8; author reply 1976-8. PubMed ID: 12477952
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute coronary syndromes--beyond myocyte necrosis.
    Rabbani LE
    N Engl J Med; 2001 Oct; 345(14):1057-9. PubMed ID: 11586960
    [No Abstract]   [Full Text] [Related]  

  • 17. B-type natriuretic peptide and acute coronary syndromes.
    Kalra PR; Sharma R; Struthers AD
    N Engl J Med; 2002 Feb; 346(6):453-5. PubMed ID: 11837269
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of natriuretic peptides in heart failure].
    Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
    Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
    Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
    Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.